Abstract
Purpose
Clostridium difficile colitis (CDC) has a clinical spectrum ranging from mild diarrhea to fulminant, potentially fatal colitis. The pathophysiology for this variation remains poorly understood. A total abdominal colectomy may be lifesaving if performed before the point of no return. Identification of negative prognostic factors is desperately needed for optimization of the clinical and operative management.
Methods
In-patients with CDC between 1999 and 2006 were identified through the discharge database (ICD-9: 008.45). Of these, patients with positive ELISA toxin or biopsy were included. Excluded were ELISA-negative patients. Data collected included general demographics, underlying medical conditions, APACHE II score, clinical and laboratory data, and duration of the medical treatment. Mortality and cure were the two endpoints. Regression analysis was used to identify parameters associated with mortality.
Results
Three hundred ninety-eight patients (mean age 59, range 19–94) with CDC were analyzed. Fourteen patients (3.52%) underwent surgery. Mortality in the cohort was 10.3% (41/398 patients). Patients with fatal outcome had a longer pre-CDC hospital stay (11 vs. 6 days). Mortality was significantly (p < 0.05) associated with a higher APACHE II score, a higher ASA class, a lower diastolic blood pressure, preexisting pulmonary and renal disease, use of steroids, evidence of toxic megacolon, higher WBCs, and clinical signs of sepsis and organ dysfunction (renal and pulmonary). Parameters without significant difference (p > 0.05) included patient age, albumin, clinical presentation/examination parameters, and transplant status, other than the mentioned comorbidities. Of the 41 fatal outcomes, five patients (12.2%) underwent surgery, and 36 did not (87.8%). Mortality rate of the surgical group was 35.7% (four out of 14 patients). Comparison of the fatalities not undergoing surgery with the survivors revealed decreased clinical signs, suggesting a masking of the disease severity.
Conclusions
Our study identified several clinical factors, which were associated with mortality from CDC. Future clinical studies will have to focus on the disease progression and the fatalities occurring either without an attempt for or despite surgical intervention, as an earlier intervention might have proven lifesaving.
Similar content being viewed by others
Abbreviations
- ASA:
-
American Society of Anesthesiologists
- CDC:
-
C. difficile colitis
- LOS:
-
Length of hospital stay
- WBC:
-
White blood cells
References
Kaiser AM. McGraw-Hill’s Manual of Colorectal Surgery. 1st ed. New York: McGraw-Hill, 2008.
Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008;46(Suppl 1):S12–18.
Mitty RD, LaMont JT. Clostridium difficile diarrhea: pathogenesis, epidemiology, and treatment. Gastroenterologist 1994;2(1):61–69.
Shen EP, Surawicz CM. The changing face of Clostridium difficile: what treatment options remain? Am J Gastroenterol 2007;102(12):2789–2792.
Gerding DN, Muto CA, Owens RC Jr. Treatment of Clostridium difficile infection. Clin Infect Dis 2008;46(Suppl 1):S32–42.
Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007;142(7):624–631. discussion 31.
Koss K, Clark MA, Sanders DS, Morton D, Keighley MR, Goh J. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis 2006;8(2):149–154.
McFarland LV. Update on the changing epidemiology of Clostridium difficile-associated disease. Nature Clinical Practice Gastroenterology & Hepatology 2008;5(1):40–48.
Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353(23):2442–2449.
Hermsen JL, Dobrescu C, Kudsk KA. Clostridium difficile infection: a surgical disease in evolution. J Gastrointest Surg 2008;12(9):1512–1517.
Pepin J, Valiquette L, Gagnon S, Routhier S, Brazeau I. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Am J Gastroenterol 2007;102(12):2781–2788.
Byrn JC, Maun DC, Gingold DS, Baril DT, Ozao JJ, Divino CM. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg 2008;143(2):150–154. discussion 5.
Kaplan GG, McCarthy EP, Ayanian JZ, Korzenik J, Hodin R, Sands BE. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology 2008;134(3):680–687.
Adams SD, Mercer DW. Fulminant Clostridium difficile colitis. Curr Opin Crit Care 2007;13(4):450–455.
Lamontagne F, Labbe AC, Haeck O et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg 2007;245(2):267–272.
Ali SO, Welch JP, Dring RJ. Early surgical intervention for fulminant pseudomembranous colitis. Am Surg 2008;74(1):20–26.
Hall JF, Berger D. Outcome of colectomy for Clostridium difficile colitis: a plea for early surgical management. Am J Surg 2008;196(3):384–388.
Pepin J, Truc Vo T, Boutros M et al. Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum 2009;52(3):400–405.
Kyne L, Merry C, O’Connell B, Kelly A, Keane C, O’Neill D. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age & Ageing 1999;28(2):107–113.
Keven K, Basu A, Re L et al. Clostridium difficile colitis in patients after kidney and pancreas–kidney transplantation. Transpl Infect Dis 2004;6(1):10–14.
Gellad ZF, Alexander BD, Liu JK et al. Severity of Clostridium difficile-associated diarrhea in solid organ transplant patients. Transpl Infect Dis 2007;9(4):276–280.
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13(10):818–829.
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper was read as a podium presentation at the 2008 Annual meeting of the American Society of Colon and Rectal Surgeons in Boston, MA (June 7–11, 2008).
Rights and permissions
About this article
Cite this article
Dudukgian, H., Sie, E., Gonzalez-Ruiz, C. et al. C. difficile Colitis—Predictors of Fatal Outcome. J Gastrointest Surg 14, 315–322 (2010). https://doi.org/10.1007/s11605-009-1093-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-009-1093-2